Table of Content

1 Equine Rabies Immunoglobulin (ERIG) Market Overview
1.1 Product Overview and Scope of Equine Rabies Immunoglobulin (ERIG)
1.2 Equine Rabies Immunoglobulin (ERIG) Segment by Type
1.2.1 Global Equine Rabies Immunoglobulin (ERIG) Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 1500IU
1.2.3 1000IU
1.2.4 400IU
1.2.5 Other
1.3 Equine Rabies Immunoglobulin (ERIG) Segment by Application
1.3.1 Equine Rabies Immunoglobulin (ERIG) Sales Comparison by Application: (2021-2027)
1.3.2 Category II Exposure
1.3.3 Category III Exposure
1.4 Global Equine Rabies Immunoglobulin (ERIG) Market Size Estimates and Forecasts
1.4.1 Global Equine Rabies Immunoglobulin (ERIG) Revenue 2016-2027
1.4.2 Global Equine Rabies Immunoglobulin (ERIG) Sales 2016-2027
1.4.3 Equine Rabies Immunoglobulin (ERIG) Market Size by Region: 2016 Versus 2021 Versus 2027

2 Equine Rabies Immunoglobulin (ERIG) Market Competition by Manufacturers
2.1 Global Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Manufacturers (2016-2021)
2.2 Global Equine Rabies Immunoglobulin (ERIG) Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Equine Rabies Immunoglobulin (ERIG) Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Equine Rabies Immunoglobulin (ERIG) Manufacturing Sites, Area Served, Product Type
2.5 Equine Rabies Immunoglobulin (ERIG) Market Competitive Situation and Trends
2.5.1 Equine Rabies Immunoglobulin (ERIG) Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Equine Rabies Immunoglobulin (ERIG) Players Market Share by Revenue
2.5.3 Global Equine Rabies Immunoglobulin (ERIG) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Equine Rabies Immunoglobulin (ERIG) Retrospective Market Scenario by Region
3.1 Global Equine Rabies Immunoglobulin (ERIG) Retrospective Market Scenario in Revenue by Region: 2016-2021
3.2 Global Equine Rabies Immunoglobulin (ERIG) Retrospective Market Scenario in Sales by Region: 2016-2021
3.3 North America Equine Rabies Immunoglobulin (ERIG) Market Facts & Figures by Country
3.3.1 North America Equine Rabies Immunoglobulin (ERIG) Sales by Country
3.3.2 North America Equine Rabies Immunoglobulin (ERIG) Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Equine Rabies Immunoglobulin (ERIG) Market Facts & Figures by Country
3.4.1 Europe Equine Rabies Immunoglobulin (ERIG) Sales by Country
3.4.2 Europe Equine Rabies Immunoglobulin (ERIG) Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Equine Rabies Immunoglobulin (ERIG) Market Facts & Figures by Region
3.5.1 Asia Pacific Equine Rabies Immunoglobulin (ERIG) Sales by Region
3.5.2 Asia Pacific Equine Rabies Immunoglobulin (ERIG) Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Equine Rabies Immunoglobulin (ERIG) Market Facts & Figures by Country
3.6.1 Latin America Equine Rabies Immunoglobulin (ERIG) Sales by Country
3.6.2 Latin America Equine Rabies Immunoglobulin (ERIG) Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Equine Rabies Immunoglobulin (ERIG) Market Facts & Figures by Country
3.7.1 Middle East and Africa Equine Rabies Immunoglobulin (ERIG) Sales by Country
3.7.2 Middle East and Africa Equine Rabies Immunoglobulin (ERIG) Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Equine Rabies Immunoglobulin (ERIG) Historic Market Analysis by Type
4.1 Global Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Type (2016-2021)
4.2 Global Equine Rabies Immunoglobulin (ERIG) Revenue Market Share by Type (2016-2021)
4.3 Global Equine Rabies Immunoglobulin (ERIG) Price by Type (2016-2021)

5 Global Equine Rabies Immunoglobulin (ERIG) Historic Market Analysis by Application
5.1 Global Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Application (2016-2021)
5.2 Global Equine Rabies Immunoglobulin (ERIG) Revenue Market Share by Application (2016-2021)
5.3 Global Equine Rabies Immunoglobulin (ERIG) Price by Application (2016-2021)

6 Key Companies Profiled
6.1 Serum China
6.1.1 Serum China Corporation Information
6.1.2 Serum China Description and Business Overview
6.1.3 Serum China Equine Rabies Immunoglobulin (ERIG) Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Serum China Product Portfolio
6.1.5 Serum China Recent Developments/Updates
6.2 Lanzhou Institute of Biological Products
6.2.1 Lanzhou Institute of Biological Products Corporation Information
6.2.2 Lanzhou Institute of Biological Products Description and Business Overview
6.2.3 Lanzhou Institute of Biological Products Equine Rabies Immunoglobulin (ERIG) Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Lanzhou Institute of Biological Products Product Portfolio
6.2.5 Lanzhou Institute of Biological Products Recent Developments/Updates
6.3 Wuhan Institute of Biological Products
6.3.1 Wuhan Institute of Biological Products Corporation Information
6.3.2 Wuhan Institute of Biological Products Description and Business Overview
6.3.3 Wuhan Institute of Biological Products Equine Rabies Immunoglobulin (ERIG) Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Wuhan Institute of Biological Products Product Portfolio
6.3.5 Wuhan Institute of Biological Products Recent Developments/Updates
6.4 Premium Serums
6.4.1 Premium Serums Corporation Information
6.4.2 Premium Serums Description and Business Overview
6.4.3 Premium Serums Equine Rabies Immunoglobulin (ERIG) Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Premium Serums Product Portfolio
6.4.5 Premium Serums Recent Developments/Updates
6.5 Haffkine Bio-Pharmaceutical
6.5.1 Haffkine Bio-Pharmaceutical Corporation Information
6.5.2 Haffkine Bio-Pharmaceutical Description and Business Overview
6.5.3 Haffkine Bio-Pharmaceutical Equine Rabies Immunoglobulin (ERIG) Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Haffkine Bio-Pharmaceutical Product Portfolio
6.5.5 Haffkine Bio-Pharmaceutical Recent Developments/Updates
6.6 Bharat Serums
6.6.1 Bharat Serums Corporation Information
6.6.2 Bharat Serums Description and Business Overview
6.6.3 Bharat Serums Equine Rabies Immunoglobulin (ERIG) Sales, Revenue and Gross Margin (2016-2021)
6.6.4 Bharat Serums Product Portfolio
6.6.5 Bharat Serums Recent Developments/Updates

7 Equine Rabies Immunoglobulin (ERIG) Manufacturing Cost Analysis
7.1 Equine Rabies Immunoglobulin (ERIG) Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Equine Rabies Immunoglobulin (ERIG)
7.4 Equine Rabies Immunoglobulin (ERIG) Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Equine Rabies Immunoglobulin (ERIG) Distributors List
8.3 Equine Rabies Immunoglobulin (ERIG) Customers

9 Equine Rabies Immunoglobulin (ERIG) Market Dynamics
9.1 Equine Rabies Immunoglobulin (ERIG) Industry Trends
9.2 Equine Rabies Immunoglobulin (ERIG) Growth Drivers
9.3 Equine Rabies Immunoglobulin (ERIG) Market Challenges
9.4 Equine Rabies Immunoglobulin (ERIG) Market Restraints

10 Global Market Forecast
10.1 Equine Rabies Immunoglobulin (ERIG) Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Equine Rabies Immunoglobulin (ERIG) by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Equine Rabies Immunoglobulin (ERIG) by Type (2022-2027)
10.2 Equine Rabies Immunoglobulin (ERIG) Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Equine Rabies Immunoglobulin (ERIG) by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Equine Rabies Immunoglobulin (ERIG) by Application (2022-2027)
10.3 Equine Rabies Immunoglobulin (ERIG) Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Equine Rabies Immunoglobulin (ERIG) by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Equine Rabies Immunoglobulin (ERIG) by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Equine Rabies Immunoglobulin (ERIG) Sales (K Units) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Equine Rabies Immunoglobulin (ERIG) Sales (K Units) Comparison by Application (2021-2027)
Table 3. Global Equine Rabies Immunoglobulin (ERIG) Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Equine Rabies Immunoglobulin (ERIG) Covered in This Study
Table 5. Global Equine Rabies Immunoglobulin (ERIG) Sales (K Units) of Key Manufacturers (2016-2021)
Table 6. Global Equine Rabies Immunoglobulin (ERIG) Sales Share by Manufacturers (2016-2021)
Table 7. Global Equine Rabies Immunoglobulin (ERIG) Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Equine Rabies Immunoglobulin (ERIG) Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Equine Rabies Immunoglobulin (ERIG) Average Price (US$/Unit) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Equine Rabies Immunoglobulin (ERIG) Manufacturing Sites and Area Served
Table 11. Manufacturers Equine Rabies Immunoglobulin (ERIG) Product Type
Table 12. Global Equine Rabies Immunoglobulin (ERIG) Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Equine Rabies Immunoglobulin (ERIG) by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Equine Rabies Immunoglobulin (ERIG) as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Equine Rabies Immunoglobulin (ERIG) Sales by Region (2016-2021) & (K Units)
Table 16. Global Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Region (2016-2021)
Table 17. Global Equine Rabies Immunoglobulin (ERIG) Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Equine Rabies Immunoglobulin (ERIG) Sales by Country (2016-2021) & (K Units)
Table 19. North America Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Country (2016-2021)
Table 20. North America Equine Rabies Immunoglobulin (ERIG) Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Equine Rabies Immunoglobulin (ERIG) Revenue Market Share by Country (2016-2021)
Table 22. Europe Equine Rabies Immunoglobulin (ERIG) Sales by Country (2016-2021) & (K Units)
Table 23. Europe Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Country (2016-2021)
Table 24. Europe Equine Rabies Immunoglobulin (ERIG) Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Equine Rabies Immunoglobulin (ERIG) Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Equine Rabies Immunoglobulin (ERIG) Sales by Region (2016-2021) & (K Units)
Table 27. Asia Pacific Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Equine Rabies Immunoglobulin (ERIG) Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Equine Rabies Immunoglobulin (ERIG) Revenue Market Share by Region (2016-2021)
Table 30. Latin America Equine Rabies Immunoglobulin (ERIG) Sales by Country (2016-2021) & (K Units)
Table 31. Latin America Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Country (2016-2021)
Table 32. Latin America Equine Rabies Immunoglobulin (ERIG) Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Equine Rabies Immunoglobulin (ERIG) Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Equine Rabies Immunoglobulin (ERIG) Sales by Country (2016-2021) & (K Units)
Table 35. Middle East and Africa Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Equine Rabies Immunoglobulin (ERIG) Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Equine Rabies Immunoglobulin (ERIG) Revenue Market Share by Country (2016-2021)
Table 38. Global Equine Rabies Immunoglobulin (ERIG) Sales (K Units) by Type (2016-2021)
Table 39. Global Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Type (2016-2021)
Table 40. Global Equine Rabies Immunoglobulin (ERIG) Revenue (Million US$) by Type (2016-2021)
Table 41. Global Equine Rabies Immunoglobulin (ERIG) Revenue Share by Type (2016-2021)
Table 42. Global Equine Rabies Immunoglobulin (ERIG) Price (US$/Unit) by Type (2016-2021)
Table 43. Global Equine Rabies Immunoglobulin (ERIG) Sales (K Units) by Application (2016-2021)
Table 44. Global Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Application (2016-2021)
Table 45. Global Equine Rabies Immunoglobulin (ERIG) Revenue (Million US$) by Application (2016-2021)
Table 46. Global Equine Rabies Immunoglobulin (ERIG) Revenue Share by Application (2016-2021)
Table 47. Global Equine Rabies Immunoglobulin (ERIG) Price (US$/Unit) by Application (2016-2021)
Table 48. Serum China Corporation Information
Table 49. Serum China Description and Business Overview
Table 50. Serum China Equine Rabies Immunoglobulin (ERIG) Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 51. Serum China Equine Rabies Immunoglobulin (ERIG) Product
Table 52. Serum China Recent Developments/Updates
Table 53. Lanzhou Institute of Biological Products Corporation Information
Table 54. Lanzhou Institute of Biological Products Description and Business Overview
Table 55. Lanzhou Institute of Biological Products Equine Rabies Immunoglobulin (ERIG) Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 56. Lanzhou Institute of Biological Products Equine Rabies Immunoglobulin (ERIG) Product
Table 57. Lanzhou Institute of Biological Products Recent Developments/Updates
Table 58. Wuhan Institute of Biological Products Corporation Information
Table 59. Wuhan Institute of Biological Products Description and Business Overview
Table 60. Wuhan Institute of Biological Products Equine Rabies Immunoglobulin (ERIG) Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 61. Wuhan Institute of Biological Products Equine Rabies Immunoglobulin (ERIG) Product
Table 62. Wuhan Institute of Biological Products Recent Developments/Updates
Table 63. Premium Serums Corporation Information
Table 64. Premium Serums Description and Business Overview
Table 65. Premium Serums Equine Rabies Immunoglobulin (ERIG) Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 66. Premium Serums Equine Rabies Immunoglobulin (ERIG) Product
Table 67. Premium Serums Recent Developments/Updates
Table 68. Haffkine Bio-Pharmaceutical Corporation Information
Table 69. Haffkine Bio-Pharmaceutical Description and Business Overview
Table 70. Haffkine Bio-Pharmaceutical Equine Rabies Immunoglobulin (ERIG) Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 71. Haffkine Bio-Pharmaceutical Equine Rabies Immunoglobulin (ERIG) Product
Table 72. Haffkine Bio-Pharmaceutical Recent Developments/Updates
Table 73. Bharat Serums Corporation Information
Table 74. Bharat Serums Description and Business Overview
Table 75. Bharat Serums Equine Rabies Immunoglobulin (ERIG) Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 76. Bharat Serums Equine Rabies Immunoglobulin (ERIG) Product
Table 77. Bharat Serums Recent Developments/Updates
Table 78. Production Base and Market Concentration Rate of Raw Material
Table 79. Key Suppliers of Raw Materials
Table 80. Equine Rabies Immunoglobulin (ERIG) Distributors List
Table 81. Equine Rabies Immunoglobulin (ERIG) Customers List
Table 82. Equine Rabies Immunoglobulin (ERIG) Market Trends
Table 83. Equine Rabies Immunoglobulin (ERIG) Growth Drivers
Table 84. Equine Rabies Immunoglobulin (ERIG) Market Restraints
Table 85. Global Equine Rabies Immunoglobulin (ERIG) Sales Forecast by Type (2022-2027) & (K Units)
Table 86. Global Equine Rabies Immunoglobulin (ERIG) Sales Market Share Forecast by Type (2022-2027)
Table 87. Global Equine Rabies Immunoglobulin (ERIG) Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 88. Global Equine Rabies Immunoglobulin (ERIG) Revenue Market Share Forecast by Type (2022-2027)
Table 89. Global Equine Rabies Immunoglobulin (ERIG) Sales Forecast by Application (2022-2027) & (K Units)
Table 90. Global Equine Rabies Immunoglobulin (ERIG) Sales Market Share Forecast by Application (2022-2027)
Table 91. Global Equine Rabies Immunoglobulin (ERIG) Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 92. Global Equine Rabies Immunoglobulin (ERIG) Revenue Market Share Forecast by Application (2022-2027)
Table 93. Global Equine Rabies Immunoglobulin (ERIG) Sales Forecast by Region (2022-2027) & (K Units)
Table 94. Global Equine Rabies Immunoglobulin (ERIG) Sales Market Share Forecast by Region (2022-2027)
Table 95. Global Equine Rabies Immunoglobulin (ERIG) Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 96. Global Equine Rabies Immunoglobulin (ERIG) Revenue Market Share Forecast by Region (2022-2027)
Table 97. Research Programs/Design for This Report
Table 98. Key Data Information from Secondary Sources
Table 99. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Equine Rabies Immunoglobulin (ERIG)
Figure 2. Global Equine Rabies Immunoglobulin (ERIG) Market Share by Type in 2020 & 2027
Figure 3. 1500IU Product Picture
Figure 4. 1000IU Product Picture
Figure 5. 400IU Product Picture
Figure 6. Other Product Picture
Figure 7. Global Equine Rabies Immunoglobulin (ERIG) Market Share by Application in 2020 & 2027
Figure 8. Category II Exposure
Figure 9. Category III Exposure
Figure 10. Global Equine Rabies Immunoglobulin (ERIG) Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Equine Rabies Immunoglobulin (ERIG) Market Size 2016-2027 (US$ Million)
Figure 12. Global Equine Rabies Immunoglobulin (ERIG) Sales 2016-2027 (K Units)
Figure 13. Global Equine Rabies Immunoglobulin (ERIG) Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 14. Equine Rabies Immunoglobulin (ERIG) Sales Share by Manufacturers in 2020
Figure 15. Global Equine Rabies Immunoglobulin (ERIG) Revenue Share by Manufacturers in 2020
Figure 16. The Global 5 and 10 Largest Equine Rabies Immunoglobulin (ERIG) Players: Market Share by Revenue in 2020
Figure 17. Equine Rabies Immunoglobulin (ERIG) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 18. Global Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Region (2016-2021)
Figure 19. Global Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Region in 2020
Figure 20. Global Equine Rabies Immunoglobulin (ERIG) Revenue Market Share by Region (2016-2021)
Figure 21. Global Equine Rabies Immunoglobulin (ERIG) Revenue Market Share by Region in 2020
Figure 22. U.S. Equine Rabies Immunoglobulin (ERIG) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 23. Canada Equine Rabies Immunoglobulin (ERIG) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 24. Germany Equine Rabies Immunoglobulin (ERIG) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 25. France Equine Rabies Immunoglobulin (ERIG) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. U.K. Equine Rabies Immunoglobulin (ERIG) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. Italy Equine Rabies Immunoglobulin (ERIG) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. Russia Equine Rabies Immunoglobulin (ERIG) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. China Equine Rabies Immunoglobulin (ERIG) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. Japan Equine Rabies Immunoglobulin (ERIG) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. South Korea Equine Rabies Immunoglobulin (ERIG) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. India Equine Rabies Immunoglobulin (ERIG) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. Australia Equine Rabies Immunoglobulin (ERIG) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. Taiwan Equine Rabies Immunoglobulin (ERIG) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. Indonesia Equine Rabies Immunoglobulin (ERIG) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Thailand Equine Rabies Immunoglobulin (ERIG) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Malaysia Equine Rabies Immunoglobulin (ERIG) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Philippines Equine Rabies Immunoglobulin (ERIG) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Vietnam Equine Rabies Immunoglobulin (ERIG) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Mexico Equine Rabies Immunoglobulin (ERIG) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Brazil Equine Rabies Immunoglobulin (ERIG) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Argentina Equine Rabies Immunoglobulin (ERIG) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Turkey Equine Rabies Immunoglobulin (ERIG) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Saudi Arabia Equine Rabies Immunoglobulin (ERIG) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. UAE Equine Rabies Immunoglobulin (ERIG) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 46. Sales Market Share of Equine Rabies Immunoglobulin (ERIG) by Type (2016-2021)
Figure 47. Sales Market Share of Equine Rabies Immunoglobulin (ERIG) by Application (2016-2021)
Figure 48. Sales Market Share of Equine Rabies Immunoglobulin (ERIG) by Application in 2020
Figure 49. Revenue Share of Equine Rabies Immunoglobulin (ERIG) by Application (2016-2021)
Figure 50. Revenue Share of Equine Rabies Immunoglobulin (ERIG) by Application in 2020
Figure 51. Manufacturing Cost Structure of Equine Rabies Immunoglobulin (ERIG)
Figure 52. Manufacturing Process Analysis of Equine Rabies Immunoglobulin (ERIG)
Figure 53. Equine Rabies Immunoglobulin (ERIG) Industrial Chain Analysis
Figure 54. Channels of Distribution
Figure 55. Distributors Profiles
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed